The effects of designed angiopoietin-1 variant on lipid droplet diameter, vascular endothelial cell density and metabolic parameters in diabetic db/db mice

Biochemical and Biophysical Research Communications

Volumn 420, Issue 3, 2012, Pages 498-504

  Jung, Yu Jin ^a   Choi, Hyun Ju ^a   Lee, Jung Eun ^a   Lee, Ae Sin ^a   Kang, Kyung Pyo ^a   Lee, Sik ^a   Park, Sung Kwang ^a   Park, Tae Sun ^a   Jin, Heung Yong ^a   Lee, Sang Young ^a   Kim, Duk Hoon ^b   Kim, Won ^a  

^a Chonbuk National University Medical School   (South Korea)

^b National Forensic Service   (South Korea)

Author keywords

Angiopoietin 1; Endothelial cells; Fat droplet; Insulin resistance

Indexed keywords

ANGIOPOIETIN 1; COMP ANGIOPOIETIN 1; FAT DROPLET; GLUCOSE; RESISTIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ABDOMINAL FAT; ADENOVIRUS; ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL DENSITY; CONTROLLED STUDY; FLUID INTAKE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; INSULIN RESISTANCE; LIPID DIET; MALE; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

ADIPOCYTES; ANIMALS; ANTI-OBESITY AGENTS; ANTIGENS, CD31; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS; DRINKING; ENDOTHELIUM, VASCULAR; FASTING; INTRA-ABDOMINAL FAT; LIPID METABOLISM; MALE; MICE; MICE, INBRED C57BL; RECOMBINANT FUSION PROTEINS; RESISTIN; TUMOR NECROSIS FACTOR-ALPHA;

ADENOVIRIDAE; MUS;

EID: 84859577496     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.03.019     Document Type: Article

References (34)

1. Goldstein B.J. Insulin resistance as the core defect in type 2 diabetes mellitus. Am. J. Cardiol. 2002, 90:3G-10G.
2. Hotamisligil G.S. Molecular mechanisms of insulin resistance and the role of the adipocyte. Int. J. Obes. Relat. Metab. Disord. 2000, 24(Suppl. 4):S23-S27.
3. Arner P. The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones. Trends Endocrinol. Metab. 2003, 14:137-145.
4. Miyoshi H., Perfield J.W., Obin M.S., Greenberg A.S. Adipose triglyceride lipase regulates basal lipolysis and lipid droplet size in adipocytes. J. Cell. Biochem. 2008, 105:1430-1436.
5. Skurk T., Alberti-Huber C., Herder C., Hauner H. Relationship between adipocyte size and adipokine expression and secretion. J. Clin. Endocrinol. Metab. 2007, 92:1023-1033.
6. O'Connell J., Lynch L., Cawood T.J., Kwasnik A., Nolan N., Geoghegan J., McCormick A., O'Farrelly C., O'Shea D. The relationship of omental and subcutaneous adipocyte size to metabolic disease in severe obesity. PLoS One 2010, 5:e9997.
7. Koska J., Stefan N., Permana P.A., Weyer C., Sonoda M., Bogardus C., Smith S.R., Joanisse D.R., Funahashi T., Krakoff J., Bunt J.C. Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals. Am. J. Clin. Nutr. 2008, 87:295-302.
8. Yin J., Gao Z., He Q., Zhou D., Guo Z., Ye J. Role of hypoxia in obesity-induced disorders of glucose and lipid metabolism in adipose tissue. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E333-E342.
9. Ye J. Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int. J. Obes. (Lond.) 2009, 33:54-66.
10. Hosogai N., Fukuhara A., Oshima K., Miyata Y., Tanaka S., Segawa K., Furukawa S., Tochino Y., Komuro R., Matsuda M., Shimomura I. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 2007, 56:901-911.
11. Pasarica M., Sereda O.R., Redman L.M., Albarado D.C., Hymel D.T., Roan L.E., Rood J.C., Burk D.H., Smith S.R. Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes 2009, 58:718-725.
12. Michailidou Z., Turban S., Miller E., Zou X., Schrader J., Ratcliffe P.J., Hadoke P.W., Walker B.R., Iredale J.P., Morton N.M., Seckl J.R. Increased angiogenesis protects against adipose hypoxia and fibrosis in metabolic disease-resistant 11beta-hydroxysteroid dehydrogenase type 1 (HSD1)-deficient mice. J. Biol. Chem. 2012, 287:4188-4197.
13. Suri C., Jones P.F., Patan S., Bartunkova S., Maisonpierre P.C., Davis S., Sato T.N., Yancopoulos G.D. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996, 87:1171-1180.
14. Davis S., Aldrich T.H., Jones P.F., Acheson A., Compton D.L., Jain V., Ryan T.E., Bruno J., Radziejewski C., Maisonpierre P.C., Yancopoulos G.D. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996, 87:1161-1169.
15. Arai F., Hirao A., Ohmura M., Sato H., Matsuoka S., Takubo K., Ito K., Koh G.Y., Suda T. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 2004, 118:149-161.
16. Moon W.S., Park H.S., Yu K.H., Jang K.Y., Kang M.J., Park H., Tarnawski A.S. Expression of angiopoietin 1, 2 and their common receptor Tie2 in human gastric carcinoma: implication for angiogenesis. J. Korean Med. Sci. 2006, 21:272-278.
17. Saito M., Watanabe J., Fujisawa T., Kamata Y., Nishimura Y., Arai T., Miyamoto T., Obokata A., Kuramoto H. Angiopoietin-1, 2 and Tie2 expressions in endometrial adenocarcinoma-The Ang2 dominant balance up-regulates tumor angiogenesis in the presence of VEGF. Eur. J. Gynaecol. Oncol. 2006, 27:129-134.
18. Kwak H.J., Lee S.J., Lee Y.H., Ryu C.H., Koh K.N., Choi H.Y., Koh G.Y. Angiopoietin-1 inhibits irradiation- and mannitol-induced apoptosis in endothelial cells. Circulation 2000, 101:2317-2324.
19. Kwak H.J., So J.N., Lee S.J., Kim I., Koh G.Y. Angiopoietin-1 is an apoptosis survival factor for endothelial cells. FEBS Lett. 1999, 448:249-253.
20. Simoes D.C., Vassilakopoulos T., Toumpanakis D., Petrochilou K., Roussos C., Papapetropoulos A. Angiopoietin-1 protects against airway inflammation and hyperreactivity in asthma. Am. J. Respir. Crit. Care Med. 2008, 177:1314-1321.
21. Cho C.H., Kammerer R.A., Lee H.J., Yasunaga K., Kim K.T., Choi H.H., Kim W., Kim S.H., Park S.K., Lee G.M., Koh G.Y. Designed angiopoietin-1 variant, COMP-Ang1, protects against radiation-induced endothelial cell apoptosis. Proc. Natl. Acad. Sci. USA 2004, 101:5553-5558.
22. Cho C.H., Kammerer R.A., Lee H.J., Steinmetz M.O., Ryu Y.S., Lee S.H., Yasunaga K., Kim K.T., Kim I., Choi H.H., Kim W., Kim S.H., Park S.K., Lee G.M., Koh G.Y. COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity. Proc. Natl. Acad. Sci. USA 2004, 101:5547-5552.
23. Kim W., Moon S.O., Lee S.Y., Jang K.Y., Cho C.H., Koh G.Y., Choi K.S., Yoon K.H., Sung M.J., Kim D.H., Lee S., Kang K.P., Park S.K. COMP-angiopoietin-1 ameliorates renal fibrosis in a unilateral ureteral obstruction model. J. Am. Soc. Nephrol. 2006, 17:2474-2483.
24. Sung H.K., Kim Y.W., Choi S.J., Kim J.Y., Jeune K.H., Won K.C., Kim J.K., Koh G.Y., Park S.Y. COMP-angiopoietin-1 enhances skeletal muscle blood flow and insulin sensitivity in mice. Am. J. Physiol. Endocrinol. Metab. 2009, 297:E402-409.
25. Lee S., Kim W., Moon S.O., Sung M.J., Kim D.H., Kang K.P., Jang K.Y., Lee S.Y., Park B.H., Koh G.Y., Park S.K. Renoprotective effect of COMP-angiopoietin-1 in db/db mice with type 2 diabetes. Nephrol. Dial. Transplant. 2007, 22:396-408.
26. Jin H.Y., Lee K.A., Song S.K., Liu W.J., Choi J.H., Song C.H., Baek H.S., Park T.S. Sulodexide prevents peripheral nerve damage in streptozotocin induced diabetic rats. Eur. J. Pharmacol. 2012, 674:217-226.
27. Sjostrom L., Bjorntorp P., Vrana J. Microscopic fat cell size measurements on frozen-cut adipose tissue in comparison with automatic determinations of osmium-fixed fat cells. J. Lipid Res. 1971, 12:521-530.
28. Ghorbani A., Varedi M., Hadjzadeh M.A., Omrani G.H. Type-1 diabetes induces depot-specific alterations in adipocyte diameter and mass of adipose tissues in the rat. Exp. Clin. Endocrinol. Diabetes 2010, 118:442-448.
29. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
30. Kershaw E.E., Flier J.S. Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 2004, 89:2548-2556.
31. Scherer P.E. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006, 55:1537-1545.
32. Salans L.B., Knittle J.L., Hirsch J. The role of adipose cell size and adipose tissue insulin sensitivity in the carbohydrate intolerance of human obesity. J. Clin. Invest. 1968, 47:153-165.
33. Xu F., Burk D., Gao Z., Yin J., Zhang X., Weng J., Ye J. Angiogenic deficiency and adipose tissue dysfunction are associated with macrophage malfunction in SIRT1-/- mice. Endocrinology 2012, http://dx.doi.org/10.1210en.2011-1667. [epub ahead of print].
34. Dallabrida S.M., Zurakowski D., Shih S.C., Smith L.E., Folkman J., Moulton K.S., Rupnick M.A. Adipose tissue growth and regression are regulated by angiopoietin-1. Biochem. Biophys. Res. Commun. 2003, 311:563-571.